Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
591.29
-2.10 (-0.35%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Medpace Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16,504 | 15,821 | 10,326 | 9,405 | 6,606 | 7,822 | |
Market Cap Growth | 22.08% | 53.21% | 9.79% | 42.38% | -15.54% | 57.08% |
Enterprise Value | 16,145 | 15,679 | 9,821 | 9,474 | 6,873 | 7,567 |
Last Close Price | 591.29 | 561.65 | 332.23 | 306.53 | 212.41 | 217.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.66 | 35.07 | 25.54 | 33.28 | 26.94 | 43.12 |
Forward PE | 32.30 | 33.86 | 27.33 | 31.74 | 27.33 | 42.23 |
PS Ratio | 5.93 | 6.25 | 4.90 | 4.99 | 4.53 | 6.85 |
PB Ratio | 38.04 | 34.46 | 12.51 | 16.83 | 17.10 | 8.21 |
P/TBV Ratio | - | - | 80.18 | - | - | 31.39 |
P/FCF Ratio | 23.35 | 23.20 | 18.04 | 23.71 | 18.81 | 33.28 |
P/OCF Ratio | 21.93 | 22.18 | 16.96 | 21.70 | 17.02 | 29.70 |
PEG Ratio | 2.53 | 2.43 | 1.74 | 1.24 | 1.24 | 13.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.80 | 6.20 | 4.66 | 5.02 | 4.71 | 6.62 |
EV/EBITDA Ratio | 26.42 | 27.85 | 20.63 | 26.09 | 22.83 | 34.44 |
EV/EBIT Ratio | 27.67 | 29.31 | 21.98 | 28.13 | 24.66 | 38.10 |
EV/FCF Ratio | 22.85 | 23.00 | 17.16 | 23.88 | 19.57 | 32.19 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.33 | 0.30 | 0.18 | 0.29 | 0.54 | 0.16 |
Debt / EBITDA Ratio | 0.22 | 0.23 | 0.29 | 0.41 | 0.62 | 0.59 |
Debt / FCF Ratio | 0.20 | 0.20 | 0.26 | 0.42 | 0.59 | 0.63 |
Net Debt / Equity Ratio | -0.83 | -0.78 | -0.63 | -0.14 | 0.47 | -0.33 |
Net Debt / EBITDA Ratio | -0.59 | -0.64 | -1.09 | -0.22 | 0.60 | -1.43 |
Net Debt / FCF Ratio | -0.51 | -0.53 | -0.91 | -0.20 | 0.51 | -1.34 |
Asset Turnover | 1.53 | 1.24 | 1.12 | 1.25 | 0.97 | 0.75 |
Quick Ratio | 0.66 | 0.69 | 0.90 | 0.60 | 0.37 | 1.16 |
Current Ratio | 0.73 | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 |
Return on Equity (ROE) | 162.15% | 70.23% | 58.42% | 59.83% | 36.64% | 20.68% |
Return on Assets (ROA) | 20.10% | 16.40% | 14.87% | 13.99% | 11.56% | 8.14% |
Return on Invested Capital (ROIC) | 573.33% | 219.99% | 96.91% | 54.35% | 40.12% | 27.57% |
Return on Capital Employed (ROCE) | 93.80% | 84.70% | 44.90% | 46.00% | 50.80% | 18.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.98% | 2.85% | 3.92% | 3.01% | 3.71% | 2.33% |
FCF Yield | 4.28% | 4.31% | 5.54% | 4.22% | 5.32% | 3.00% |
Buyback Yield / Dilution | 7.24% | 7.77% | -0.54% | 5.44% | 10.68% | 0.03% |